[ad_1]
[앵커]
‘Remdesivir’, an antiviral drug from the US pharmaceutical company Gilead Sciences, is used to treat seriously ill patients with Corona 19. The World Health Organization’s ‘WHO’ study found it had little real effect. In Korea, it has been used as a treatment since last July and side effects have been confirmed. This is reporter Hyungwon Lee. One of the medications that President Trump has recently been given to treat COVID-19 is remdesivir. The American pharmaceutical company Gilead Sciences developed it as a treatment for Ebola, but it was approved by the US Food and Drug Administration ‘FDA’ in May, as the effect of the Corona 19 treatment was known. Since then, it has been used as a harsh treatment for Corona 19, and the World Health Organization ‘WHO’ has published a completely different test result. In a joint clinical trial conducted since March of the 11,000 most recent hospitalized patients, there was little effect of treatment. It has not been shown to have a real impact on reducing mortality or reducing hospital stays. In Korea, it has been used to treat seriously ill patients since last July, but there has been no clear statement on the effect. As a result of the WHO study, the effect of remdesivir itself was questioned and side effects confirmed in Korea. There are 11 cases in all, including elevated levels of liver function, skin rashes, and hives. The Ministry of Food and Pharmaceutical Safety stated that there were no major cases and that the reported side effects cannot conclude that remdesivir administration has occurred. To date, more than 600 domestic patients have been treated with remdesivir. YTN Hyungwon Lee[[email protected]]is. ※ ‘Your report becomes news’ YTN awaits your valuable report.
[카카오톡] Search YTN to add a channel [전화] 02-398-8585 [메일] [email protected] [온라인 제보] www.ytn.co.kr
